147 related articles for article (PubMed ID: 7852543)
1. Craniofacial features in patients with deficient and excessive growth hormone.
Pirinen S; Majurin A; Lenko HL; Koski K
J Craniofac Genet Dev Biol; 1994; 14(3):144-52. PubMed ID: 7852543
[TBL] [Abstract][Full Text] [Related]
2. Craniofacial and acral growth responses in growth hormone-deficient children treated with growth hormone.
Segal DG; Pescovitz OH; Schaefer GB; DiMeglio LA
J Pediatr; 2004 Apr; 144(4):437-43. PubMed ID: 15069389
[TBL] [Abstract][Full Text] [Related]
3. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
Carvalho LR; de Faria ME; Osorio MG; Estefan V; Jorge AA; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
[TBL] [Abstract][Full Text] [Related]
4. Craniofacial and dental characteristics of Silver-Russell syndrome.
Kotilainen J; Hölttä P; Mikkonen T; Arte S; Sipilä I; Pirinen S
Am J Med Genet; 1995 Mar; 56(2):229-36. PubMed ID: 7625451
[TBL] [Abstract][Full Text] [Related]
5. Average craniofacial development from 6 to 35 years of age in a mixed group of patients with juvenile idiopathic arthritis.
Fjeld MG; Arvidsson LZ; Stabrun AE; Birkeland K; Larheim TA; Øgaard B
Acta Odontol Scand; 2009; 67(3):153-60. PubMed ID: 19241184
[TBL] [Abstract][Full Text] [Related]
6. Craniofacial morphology and growth in the ferret: effects from alteration of masticatory function.
He T
Swed Dent J Suppl; 2004; (165):1-72. PubMed ID: 15224640
[TBL] [Abstract][Full Text] [Related]
7. Influence of growth hormone on the craniofacial complex of transgenic mice.
Ramirez-Yañez GO; Smid JR; Young WG; Waters MJ
Eur J Orthod; 2005 Oct; 27(5):494-500. PubMed ID: 16107429
[TBL] [Abstract][Full Text] [Related]
8. Cephalometric craniofacial features of growing patients with chronic renal failure.
Al-Thomali Y; El-Bialy TH
Arch Oral Biol; 2012 Mar; 57(3):257-63. PubMed ID: 22000306
[TBL] [Abstract][Full Text] [Related]
9. The effect of growth hormone treatment on head circumference in growth hormone-deficient children.
Darendeliler F; Baş F; Gökçe M; Poyrazoğlu S; Sükür M; Bundak R; Saka N; Günöz H
Turk J Pediatr; 2008; 50(4):331-5. PubMed ID: 19014045
[TBL] [Abstract][Full Text] [Related]
10. Cephalometric evaluation of craniofacial pattern of Syrian children with Class III malocclusion.
Mouakeh M
Am J Orthod Dentofacial Orthop; 2001 Jun; 119(6):640-9. PubMed ID: 11395709
[TBL] [Abstract][Full Text] [Related]
11. Hawaiian craniofacial morphometrics: average Mokapuan skull, artificial cranial deformation, and the "rocker" mandible.
Schendel SA; Walker G; Kamisugi A
Am J Phys Anthropol; 1980 May; 52(4):491-500. PubMed ID: 7386611
[TBL] [Abstract][Full Text] [Related]
12. Semilongitudinal cephalometric study of craniofacial growth in untreated Class III malocclusion.
Alexander AE; McNamara JA; Franchi L; Baccetti T
Am J Orthod Dentofacial Orthop; 2009 Jun; 135(6):700.e1-14; discussion 700-1. PubMed ID: 19524825
[TBL] [Abstract][Full Text] [Related]
13. Analysis of craniofacial and extremity growth in patients with growth hormone deficiency during growth hormone therapy.
de Faria ME; Carvalho LR; Rossetto SM; Amaral TS; Berger K; Arnhold IJ; Mendonca BB
Horm Res; 2009; 71(3):173-7. PubMed ID: 19188743
[TBL] [Abstract][Full Text] [Related]
14. Variation in dentofacial morphology and occlusion in juvenile idiopathic arthritis subjects: a case-control study.
Hu Y; Billiau AD; Verdonck A; Wouters C; Carels C
Eur J Orthod; 2009 Feb; 31(1):51-8. PubMed ID: 19164412
[TBL] [Abstract][Full Text] [Related]
15. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
[TBL] [Abstract][Full Text] [Related]
16. Cephalometric features in isolated growth hormone deficiency.
Oliveira-Neto LA; Melo Mde F; Franco AA; Oliveira AH; Souza AH; Valença EH; Britto IM; Salvatori R; Aguiar-Oliveira MH
Angle Orthod; 2011 Jul; 81(4):578-83. PubMed ID: 21341997
[TBL] [Abstract][Full Text] [Related]
17. Nevoid Basal cell carcinoma syndrome: a cephalometric study of patients and controls.
Leonardi R; Licciardello V; Santarelli A; Ciavarella D; Bolouri S; Härle F; Caltabiano M; Lo Muzio L
J Craniofac Surg; 2009 Jan; 20(1):203-8. PubMed ID: 19165028
[TBL] [Abstract][Full Text] [Related]
18. The effect of growth hormone therapy on craniofacial growth and dental maturity in children with Down syndrome.
Carlstedt K; Annerén G; Huggare J; Modéer T; Dahllöf G
J Craniofac Genet Dev Biol; 1999; 19(1):20-3. PubMed ID: 10378144
[TBL] [Abstract][Full Text] [Related]
19. Craniofacial growth in growth hormone-deficient rats after growth hormone supplementation.
Singleton DA; Buschang PH; Behrents RG; Hinton RJ
Am J Orthod Dentofacial Orthop; 2006 Jul; 130(1):69-82. PubMed ID: 16849075
[TBL] [Abstract][Full Text] [Related]
20. Effects of growth hormone on craniofacial growth.
Funatsu M; Sato K; Mitani H
Angle Orthod; 2006 Nov; 76(6):970-7. PubMed ID: 17090153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
